G72 gene is associated with susceptibility to methamphetamine psychosis

Tatsuya Kotaka, Hiroshi Ujike, Yuko Okahisa, Manabu Takaki, Kenji Nakata, Masafumi Kodama, Toshiya Inada, Mitsuhiko Yamada, Naohisa Uchimura, Nakao Iwata, Ichiro Sora, Masaomi Iyo, Norio Ozaki, Shigetoshi Kuroda

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Methamphetamine psychosis is considered as one of the pharmacological models of schizophrenia, and a hyperdopaminergic one. However, many lines of experimental evidence indicate that glutamatergic signaling is also involved in development of methamphetamine psychosis. Several genes related to glutamate function, e.g. the DTNBP1, G72, and GRM3 genes, were shown to be associated with schizophrenia susceptibility. Recently, we found significant association of the DTNBP1 gene with methamphetamine psychosis. This finding prompted us to examine the G72 gene encoding the d-amino acid oxidase activator (DAOA), which metabolizes d-serine, an NMDA co-agonist, in methamphetamine psychosis. Six SNPs of the G72 gene, which previously showed significant association with schizophrenia, were analyzed in 209 patients with methamphetamine psychosis and 291 age- and sex-matched normal controls. One SNP of M22 (rs778293) showed a significant association with methamphetamine psychosis (genotype: p = 0.00016, allele: p = 0.0015). Two haplotypes G-A of M12 (rs3916965)-M15 (rs2391191) (p = 0.00024) and T-T of M23 (rs947267)-M24 (rs1421292) (p = 0.00085) also showed associations with methamphetamine psychosis. The present findings suggest that the G72 gene may contribute to a predisposition to not only schizophrenia but also to methamphetamine psychosis.

Original languageEnglish
Pages (from-to)1046-1049
Number of pages4
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume33
Issue number6
DOIs
Publication statusPublished - 31-08-2009

Fingerprint

Methamphetamine
Psychotic Disorders
Genes
Schizophrenia
Single Nucleotide Polymorphism
N-Methylaspartate
Serine
Haplotypes
Glutamic Acid
Oxidoreductases
Alleles
Genotype
Pharmacology
Amino Acids

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Biological Psychiatry

Cite this

Kotaka, Tatsuya ; Ujike, Hiroshi ; Okahisa, Yuko ; Takaki, Manabu ; Nakata, Kenji ; Kodama, Masafumi ; Inada, Toshiya ; Yamada, Mitsuhiko ; Uchimura, Naohisa ; Iwata, Nakao ; Sora, Ichiro ; Iyo, Masaomi ; Ozaki, Norio ; Kuroda, Shigetoshi. / G72 gene is associated with susceptibility to methamphetamine psychosis. In: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2009 ; Vol. 33, No. 6. pp. 1046-1049.
@article{06ba30cc0068438dbfe0890a25725cd9,
title = "G72 gene is associated with susceptibility to methamphetamine psychosis",
abstract = "Methamphetamine psychosis is considered as one of the pharmacological models of schizophrenia, and a hyperdopaminergic one. However, many lines of experimental evidence indicate that glutamatergic signaling is also involved in development of methamphetamine psychosis. Several genes related to glutamate function, e.g. the DTNBP1, G72, and GRM3 genes, were shown to be associated with schizophrenia susceptibility. Recently, we found significant association of the DTNBP1 gene with methamphetamine psychosis. This finding prompted us to examine the G72 gene encoding the d-amino acid oxidase activator (DAOA), which metabolizes d-serine, an NMDA co-agonist, in methamphetamine psychosis. Six SNPs of the G72 gene, which previously showed significant association with schizophrenia, were analyzed in 209 patients with methamphetamine psychosis and 291 age- and sex-matched normal controls. One SNP of M22 (rs778293) showed a significant association with methamphetamine psychosis (genotype: p = 0.00016, allele: p = 0.0015). Two haplotypes G-A of M12 (rs3916965)-M15 (rs2391191) (p = 0.00024) and T-T of M23 (rs947267)-M24 (rs1421292) (p = 0.00085) also showed associations with methamphetamine psychosis. The present findings suggest that the G72 gene may contribute to a predisposition to not only schizophrenia but also to methamphetamine psychosis.",
author = "Tatsuya Kotaka and Hiroshi Ujike and Yuko Okahisa and Manabu Takaki and Kenji Nakata and Masafumi Kodama and Toshiya Inada and Mitsuhiko Yamada and Naohisa Uchimura and Nakao Iwata and Ichiro Sora and Masaomi Iyo and Norio Ozaki and Shigetoshi Kuroda",
year = "2009",
month = "8",
day = "31",
doi = "10.1016/j.pnpbp.2009.05.017",
language = "English",
volume = "33",
pages = "1046--1049",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "6",

}

Kotaka, T, Ujike, H, Okahisa, Y, Takaki, M, Nakata, K, Kodama, M, Inada, T, Yamada, M, Uchimura, N, Iwata, N, Sora, I, Iyo, M, Ozaki, N & Kuroda, S 2009, 'G72 gene is associated with susceptibility to methamphetamine psychosis', Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 33, no. 6, pp. 1046-1049. https://doi.org/10.1016/j.pnpbp.2009.05.017

G72 gene is associated with susceptibility to methamphetamine psychosis. / Kotaka, Tatsuya; Ujike, Hiroshi; Okahisa, Yuko; Takaki, Manabu; Nakata, Kenji; Kodama, Masafumi; Inada, Toshiya; Yamada, Mitsuhiko; Uchimura, Naohisa; Iwata, Nakao; Sora, Ichiro; Iyo, Masaomi; Ozaki, Norio; Kuroda, Shigetoshi.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 33, No. 6, 31.08.2009, p. 1046-1049.

Research output: Contribution to journalArticle

TY - JOUR

T1 - G72 gene is associated with susceptibility to methamphetamine psychosis

AU - Kotaka, Tatsuya

AU - Ujike, Hiroshi

AU - Okahisa, Yuko

AU - Takaki, Manabu

AU - Nakata, Kenji

AU - Kodama, Masafumi

AU - Inada, Toshiya

AU - Yamada, Mitsuhiko

AU - Uchimura, Naohisa

AU - Iwata, Nakao

AU - Sora, Ichiro

AU - Iyo, Masaomi

AU - Ozaki, Norio

AU - Kuroda, Shigetoshi

PY - 2009/8/31

Y1 - 2009/8/31

N2 - Methamphetamine psychosis is considered as one of the pharmacological models of schizophrenia, and a hyperdopaminergic one. However, many lines of experimental evidence indicate that glutamatergic signaling is also involved in development of methamphetamine psychosis. Several genes related to glutamate function, e.g. the DTNBP1, G72, and GRM3 genes, were shown to be associated with schizophrenia susceptibility. Recently, we found significant association of the DTNBP1 gene with methamphetamine psychosis. This finding prompted us to examine the G72 gene encoding the d-amino acid oxidase activator (DAOA), which metabolizes d-serine, an NMDA co-agonist, in methamphetamine psychosis. Six SNPs of the G72 gene, which previously showed significant association with schizophrenia, were analyzed in 209 patients with methamphetamine psychosis and 291 age- and sex-matched normal controls. One SNP of M22 (rs778293) showed a significant association with methamphetamine psychosis (genotype: p = 0.00016, allele: p = 0.0015). Two haplotypes G-A of M12 (rs3916965)-M15 (rs2391191) (p = 0.00024) and T-T of M23 (rs947267)-M24 (rs1421292) (p = 0.00085) also showed associations with methamphetamine psychosis. The present findings suggest that the G72 gene may contribute to a predisposition to not only schizophrenia but also to methamphetamine psychosis.

AB - Methamphetamine psychosis is considered as one of the pharmacological models of schizophrenia, and a hyperdopaminergic one. However, many lines of experimental evidence indicate that glutamatergic signaling is also involved in development of methamphetamine psychosis. Several genes related to glutamate function, e.g. the DTNBP1, G72, and GRM3 genes, were shown to be associated with schizophrenia susceptibility. Recently, we found significant association of the DTNBP1 gene with methamphetamine psychosis. This finding prompted us to examine the G72 gene encoding the d-amino acid oxidase activator (DAOA), which metabolizes d-serine, an NMDA co-agonist, in methamphetamine psychosis. Six SNPs of the G72 gene, which previously showed significant association with schizophrenia, were analyzed in 209 patients with methamphetamine psychosis and 291 age- and sex-matched normal controls. One SNP of M22 (rs778293) showed a significant association with methamphetamine psychosis (genotype: p = 0.00016, allele: p = 0.0015). Two haplotypes G-A of M12 (rs3916965)-M15 (rs2391191) (p = 0.00024) and T-T of M23 (rs947267)-M24 (rs1421292) (p = 0.00085) also showed associations with methamphetamine psychosis. The present findings suggest that the G72 gene may contribute to a predisposition to not only schizophrenia but also to methamphetamine psychosis.

UR - http://www.scopus.com/inward/record.url?scp=67651098835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651098835&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2009.05.017

DO - 10.1016/j.pnpbp.2009.05.017

M3 - Article

C2 - 19482054

AN - SCOPUS:67651098835

VL - 33

SP - 1046

EP - 1049

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

IS - 6

ER -